| |
G/G (n=90)
|
G/A (n=106)
|
A/A (n=27)
|
P valuea
|
|---|
|
Recurrence
|
15 (16.67%)
|
30 (28.30%)
|
11 (40.74%)
|
0.021
|
|
Mortality
|
8 (8.89%)
|
15 (14.15%)
|
10 (37.04%)
|
0.002
|
|
Mean survival years
|
|
Recurrence-free
|
9.63±4.97 (0.16-21.38)
|
10.03±5.45 (0.04-24.52)
|
5.36±4.11 (0.18-17.21)
|
<0.001
|
|
Overall
|
10.30±4.67 (0.16-21.38)
|
10.98±5.32 (0.14-24.52)
|
6.33±4.00 (0.55-17.21)
|
<0.001
|
- NOTE: Data shown represent number of patients (% of n) or mean±s.d.. Bold type indicates p<0.050.
-
a, results of Chi-squared analysis or ANOVA test, depending on the type of parameter analyzed.
- Abbreviations: ER estrogen receptor, PR progesterone receptor.
